MetaCap

Illumina Earnings

NASDAQ: ILMNHealth CareMedical SpecialitiesUSD

278.17+13.60 (+5.14%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Thu, Oct 29, 2026

Fiscal period

Sep/2026

EPS estimate

$1.36

Illumina earnings summary

Illumina is scheduled to report Sep/2026 earnings on Oct 29, 2026, with analysts expecting EPS of $1.36. In its most recent report on Jul 31, 2026 (Q2 2026), ILMN posted EPS of $1.35. Revenue for the quarter was $1.16 billion.

Quarterly EPS is down 9.4% from the same quarter a year earlier. Across the last 16 reports, ILMN shares moved an average of 5.5% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

ILMN earnings history

Illumina reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 31, 2026—$1.35—-8.4%
May 4, 2026—$0.87—+0.5%
Feb 12, 2026—$2.16—+0.7%
Oct 31, 2025—$0.98—-1.3%
Aug 1, 2025—$1.49—-0.1%
May 9, 2025—$0.82—+10.4%
Feb 12, 2025—$1.16—-6.0%
Nov 6, 2024—$4.42—-10.6%
Aug 7, 2024—$-12.48—+5.5%
May 3, 2024—$-0.79—-6.3%
Feb 16, 2024—$-1.11—-7.3%
Nov 13, 2023—$-4.77—+4.3%
Aug 10, 2023—$-1.48—-7.3%
May 5, 2023—$0.02—+4.5%
Feb 17, 2023—$-0.89—-7.2%
Nov 4, 2022—$-24.26—+8.2%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related